Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6084-6090, Vol. 69, No. 10
Molecular Genetics Laboratory, International
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka-1212,
Bangladesh,1 and Department of
Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts 021152
Received 7 March 2001/Returned for modification 1 June
2001/Accepted 25 June 2001
Toxigenic Vibrio cholerae strains are lysogens of
CTX Cholera is a severe dehydrating
diarrhea caused by toxigenic strains of the gram-negative bacterium
Vibrio cholerae. The profuse watery diarrhea is mainly due
to an enterotoxin, cholera toxin (CT), produced by V. cholerae (4, 21). The ctxAB
operon, which encodes the A and B subunits of CT, resides in
the genome of CTX V. cholerae strains belonging to the O1 or O139 serogroup
are normally associated with epidemic cholera, whereas other serogroups of V. cholerae have been mostly associated with sporadic
cases of diarrhea (11). Recent studies have recorded
incidences of diarrhea outbreaks associated with non-O1 non-O139
V. cholerae, but these strains have been found to be
nontoxigenic, and the pathogenic determinants for the diarrhea have not
been identified (23). It is not clear, however, whether
transient acquisition of the CTX Bacterial strains, phages, and plasmids.
The V. cholerae non-O1 non-O139 strains included in this study were
either isolated from surface water samples collected in Dhaka,
Bangladesh, or obtained from patients with diarrhea who attended the
treatment center of the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B), located in Dhaka. A total of 37 non-O1
non-O139 strains were first tested for possession of different
virulence genes and the attRS sequence, and strains which
were negative for attRS were further analyzed in this study.
The O1 and O139 strains were attenuated derivatives of toxigenic
clinical strains described previously (1, 17, 20, 25).
Strains were stored either in lyophilized form or in sealed deep
nutrient agar at room temperature until used for the present study.
Before use, the identities of the cultures were verified by biochemical
and serological methods (29) and by using specific DNA
probes as described below. The genetically marked phage MSF8.2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6084-6090.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Diminished Diarrheal Response to Vibrio cholerae
Strains Carrying the Replicative Form of the CTX
Genome
instead of CTX
Lysogens in Adult Rabbits
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
, a filamentous bacteriophage which encodes cholera toxin (CT).
Following infection of recipient V. cholerae cells by
CTX
, the phage genome either integrates into the host chromosome at
a specific attachment site (attRS) or exists as a
replicative-form (RF) plasmid. We infected naturally occurring
attRS-negative nontoxigenic V. cholerae or attenuated (CTX
attRS negative)
derivatives of wild-type toxigenic strains with CTX
and examined the
diarrheagenic potential of the strains carrying the RF of the CTX
genome using the adult rabbit diarrhea model. Under laboratory
conditions, strains carrying the RF of CTX
produced more CT than
corresponding lysogens as assayed by a GM1-based enzyme-linked immunosorbent assay and by fluid accumulation in ligated
ileal loops of rabbits. However, when tested for diarrhea in rabbits,
the attRS-negative strains (which carried the CTX
genome as the RF) were either negative or produced mild diarrhea, whereas the attRS-positive strains with integrated
CTX
produced severe fatal diarrhea. Analysis of the strains after
intestinal passage showed that the attRS-negative
strains lost the phage genome at approximately a fivefold higher
frequency than under in vitro conditions, and 75 to 90% of cells
recovered from challenged rabbits after 24 h were CT negative.
These results suggested that strains carrying the RF of CTX
are
unable to cause severe disease due to rapid loss of the phage in vivo,
and the gastrointestinal environment thus provides selection of
toxigenic strains with an integrated CTX
genome. These results may
have implications for the development of live V.
cholerae vaccine candidates impaired in chromosomal integration
of CTX
. These findings may also contribute to understanding of the
etiology of diarrhea occasionally associated with nontoxigenic
V. cholerae strains.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
, a lysogenic filamentous bacteriophage
(27). In the natural habitat, CTX
may infect
nontoxigenic V. cholerae strains, leading to the
origination of novel toxigenic strains (5, 6). Following
entry into the recipient cells, the phage genome either integrates into
the chromosome at a specific attachment site (attRS), forming stable lysogens, or exists as a plasmid referred to as the
replicative form (RF) of the phage genome (27). Attenuated live vaccine strains are supposed to be protected from lysogenic conversion by CTX
if the attRS sequence is deleted, thus
impairing the chromosomal integration of the CTX
genome. Recently
potential vaccine strains have been developed which lack the entire CTX element, including attRS sequences (1, 14, 25,
28). A previous study has shown that V. cholerae
cells carrying the RF of the CTX
genome can produce CT under in
vitro laboratory conditions (15). However, the
diarrheagenic potential of such strains in vivo was not examined.
genome by these strains in vivo
might have led to the diarrhea. In the present study CTX
was
introduced into attRS-negative non-O1 non-O139 V. cholerae of clinical or environmental origin as well as into
attenuated (
core
attRS) derivatives of clinical V. cholerae O1 and O139 strains. The resulting strains,
which carried the RF of the CTX
genome, were tested for production of a diarrheal response in adult rabbits and for stability of the phage
genome. This study was designed to examine whether potential vaccine
strains carrying a deletion of attRS or naturally occurring attRS-negative V. cholerae strains can become
transient diarrheal pathogens by harboring the RF of the CTX
genome.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
used
in this study was a derivative of an El Tor CTX
which carried a
functional ctxAB operon as well as a kanamycin
resistance (Kmr) determinant. The strategy for
the construction of pMSF8.2 is described below. Relevant
characteristics of bacterial strains, phages, and plasmids used in this
study are summarized in Table 1.
TABLE 1.
Characteristics of bacterial strains, plasmids, and
phages used in this study
under in vitro
conditions as described previously (6, 7). Representative infected colonies were grown in Luria broth medium containing kanamycin
(50 µg/ml) and were analyzed for the presence of the phage genome.
Total DNA or plasmid DNA was extracted from overnight cultures by
standard methods (18) and purified using microcentrifuge filter units (Ultrafree-Probind; Sigma Chemical Company, St. Louis, Mo.). The presence of the phage genome as the RF or its integration into the chromosomes of the recipient cells was examined by comparative Southern blot analysis of total DNA and plasmid preparations as described previously (6, 7).
Recombinant DNA procedures.
For in vitro DNA manipulations,
pUC18, a chromogenic substrate (X-Gal
[5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside]), and DNA restriction and DNA-modifying enzymes were purchased from Bethesda Research Laboratories (Gaithersburg, Md.) and used in accordance with the manufacturer's suggestions. The strategy for the
construction of pMSF8.2, a genetically marked derivative of the RF of
the CTX
genome carrying a functional ctxAB
operon, is shown in Fig. 1.
CTX-Km
isolated from strain SM44 (10, 27) was used to
infect the classical biotype strain O395. The RF of the phage genome,
pCTX-Km isolated from strain O395, carried a Kmr
determinant in place of ctxAB genes. The entire
ctxAB operon was obtained from another recombinant
plasmid, pRT41 (26), and reinserted into pCTX-Km using a
number of cloning steps to construct pMSF8.2. Briefly, pCTX-Km was
digested with BamHI, and a 1.3-kb fragment encoding
Kmr and the remaining 6.3-kb fragment of the
phage genome were isolated. The 1.9-kb
BamHI-EcoRI insert carrying the entire
ctxAB operon, including the wild-type promoter, was
isolated from pRT41. The DNA fragments carrying the ctxAB
operon and Kmr were sequentially ligated
to BamHI-cleaved dephosphorylated pUC18. The ligated DNA was
isolated, and protruding ends were filled in using the Klenow fragment
of Escherichia coli DNA polymerase I. The resulting blunt
ends were then ligated, and the ligation mixture was used to
electroporate E. coli DH5
. Colonies which were resistant
to both kanamycin and ampicillin were screened for the presence of a
pUC18 derivative with a 3.2-kb BamHI insert carrying the
ctxAB genes and the gene encoding Kmr,
and this plasmid was designated pMSF8.1. The 3.2-kb BamHI
fragment of pMSF8.1 was isolated and ligated with the 6.3-kb
BamHI fragment of pCTX-Km. The ligated DNA was used to
electroporate V. cholerae strain O395, and colonies were
selected for resistance to kanamycin. The final plasmid construct,
designated pMSF8.2, thus consisted of a functional ctxAB
operon, a Kmr cassette, and the RF DNA of
CTX
and was able to support the morphogenesis of infectious phage
particles.
|
Probes and PCR assays.
The gene probe used in this study to
detect the CTX
genome was a 0.5-kb EcoRI fragment of
pCVD27 carrying part of the ctxA gene (12). All
strains were also tested for the presence of genes encoding the
toxin-coregulated pilus (TCP) (which is the receptor for CTX
), the
virulence regulatory gene toxR, and the CTX
attachment
sequence attRS. The presence of the TCP pathogenicity island
was determined by PCR assays specific for the tcpA,
tcpI, and acfB genes as described previously
(8, 13). The toxR gene probe was a 2.4-kb
BamHI fragment of pVM7 (19), and the 18-bp
attRS sequence was identified using a synthetic
oligonucleotide corresponding to the attRS sequence
(20).
-32P]dCTP (3,000 Ci/mmol; Amersham), and
oligonucleotide probes were labeled by 3' tailing using terminal
deoxynucleotide transferase and [
-32P]dCTP
(Amersham). Southern blots and colony blots were hybridized with the
labeled probes and autoradigraphed as described previously (6-8).
Assay for CT production.
Production of CT by V. cholerae strains harboring the RF of CTX
as well as the CTX
lysogens was determined by the GM1
ganglioside-dependent enzyme-linked immunosorbent assay (ELISA) and the
rabbit ileal loop assay as described previously (2, 8,
22). For each round of CT assay, 5 ml of AKI medium (1.5% Bacto
Peptone, 0.4% yeast extract, 0.5% NaCl, 0.3%
NaHCO3 [pH 7.4]) was inoculated with
approximately 103 bacterial cells. For strains
carrying the Kmr-labeled phage genome, kanamycin
(50 µg/ml) was added to the culture medium to retain the phage
genome. All cultures were grown for 16 h at 30°C with shaking.
The culture was centrifuged at 4,000 × g for 5 min,
and the supernatant was collected and filtered through
0.22-µm-pore-size Millipore filters. Aliquots of the undiluted supernatant, 10-fold and 100-fold dilutions of the supernatant, and
dilutions of purified CT (Sigma) were used for the toxin assay. Quantification of CT production was done using a standard curve prepared for each batch of assay mixture. The amount of CT produced by
each strain was the mean value from five different assays with the same
strain and culture conditions. Toxigenic El Tor strain P-27459 and
nontoxigenic El Tor strains SA-317 and SM44 were included as positive
and negative control strains in each round of the assay.
Ileal loop assay. Culture filtrates prepared for the ELISA were also tested in ileal loops of adult New Zealand White rabbits. A maximum of six ileal loops of approximately 10 cm in length were made in each rabbit (rabbits had previously been fasted for 48 h), and 1 ml of the filtrate was inoculated into each loop as described previously (2). After 18 h, rabbits were sacrificed and the loops were examined for fluid accumulation. The results were expressed as milliliters of fluid accumulated per centimeter of loop.
Assay for diarrhea in rabbits. Diarrheal responses to V. cholerae strains were assayed in adult rabbits by using the removable intestinal tie-adult rabbit diarrhea model (24). Adult New Zealand White rabbits weighing 1.5 to 2.7 kg were used to prepare the model. Rabbits were starved for the previous 24 h, and surgery was done under a local anesthetic. The cecum of each animal was ligated to prevent it from retaining fluid secreted by the small intestine, and a temporary removable tie of the small bowl was introduced at the time of challenge. Strains were grown in Casamino Acids-yeast extract broth as described previously (24), and cells were precipitated by centrifugation and resuspended in 10 mM phosphate-buffered saline (pH 7.4) at a concentration of approximately 109 cells per ml. One millliliter of the suspension was injected into the lumen of the anterior jejunum. The removable tie in the intestine was removed after 2 h of inoculation. Each strain was inoculated in at least five different rabbits. Rabbits were observed for overt diarrhea and for death, and stools or rectal swabs were cultured on gelatin agar plates and a duplicate plate containing kanamycin (50 µg/ml) whenever appropriate to monitor shedding of the challenge organisms. Observations were made at 6-h intervals during the 7 days following inoculation; the numbers of rabbits developing moderate to severe diarrhea were arbitrarily scored, and the numbers of deaths were recorded. Rabbits that died with or without diarrhea were subjected to postmortem examinations to check for the presence of fluid in the intestine.
Stability of the CTX
genome.
To determine the stability
of the CTX
genome in V. cholerae cells in vivo, the ratio
of Kmr colonies to the total number of colonies
recovered from stools or rectal swabs of rabbits challenged with each
strain was calculated and expressed as the percentage of cells
retaining the phage genome. To test the stability of the CTX
genome
under in vitro conditions, representative colonies of the infected
recipient were grown in aliquots of Luria broth either containing
kanamycin (50 µg/ml) or without kanamycin. Serial dilutions of the
cultures were plated on Luria agar plates containing kanamycin
and on a duplicate set of Luria agar plates without the antibiotic to
determine the proportion of cells retaining the phage genome.
Statistical analysis.
Statistical comparison of CT
production between two groups of strains was carried out by the
Mann-Whitney test. For comparison between the responses of
different proportions of rabbits to different challenge strains, the
2 statistic or Fisher's exact test was used. Differences were
considered to be significant when the P value was
0.05.
Data analyses were done by using statistical software (Sigmastat for
Windows, version 2.03; Jandel Scientific, San Rafael, Calif.).
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
We evaluated the diarrheagenic potential of strains carrying the
RF of the CTX
genome to investigate whether strains carrying a
deletion of attRS or naturally occurring
attRS-negative V. cholerae strains can
become transient diarrheal pathogens by temporarily harboring the
CTX
genome. In this study, V. cholerae strains carrying
the RF of the CTX
genome were constructed by infecting attRS-negative V. cholerae strains
with a genetically marked phage, MSF8.2
. Infected cells were
first selected by their expression of the
Kmr phenotype. While all O1 and O139 strains
which carried genes for the CTX
receptor TCP were infected by the
phage, 4 of 29 TCP-negative, attRS-negative
non-O1 strains were also infected. Previous studies have also reported
that a small proportion of TCP-negative strains were susceptible to the
phage (6). Molecular analysis of the infected strains
showed the presence of RF DNA of the phage in all
attRS-negative strains, although in control attRS-positive strains the phage genome integrated into the
chromosome (data not shown). All O1 and O139 strains as well as the
four infected non-O1 non-O139 strains (Tables
2 and 3)
were further analyzed for production of CT and for causing diarrhea in
the adult rabbit model. All of these strains carried the
toxR gene, which is required for expression of major
virulence factors in V. cholerae.
|
|
Expression of virulence.
Production of CT by the infected
cells was initially studied in vitro by GM1-based
ELISA, using an antibody against the B subunit of CT (Table 2). These
assays showed that strains carrying the RF of CTX
produced
significantly more CT than the lysogens (P < 0.01). We
suspect that the higher levels of CT produced by strains carrying the
RF were due to possession of multiple copies of the phage genome and
hence multiple copies of the ctxAB operon. In CTX
lysogens, the expression of CT is regulated by the transcriptional activator ToxR, whereas in strains carrying the RF of the CTX
genome, expression of CT is also known to occur independently of ToxR
(15). Thus, the ToxR-independent pathway of expression might also have contributed to the high levels of in vitro expression of CT by strains carrying the RF of the phage genome. To further ascertain whether the toxin was biologically active, we used the ligated ileal loop assay in rabbits and observed fluid accumulation. All culture supernatants which were positive for CT in the ELISA also
caused fluid accumulation in the ileal loops of rabbits. Culture
supernatants of strains carrying the RF of CTX
caused somewhat more
fluid accumulation in the rabbit ileal loops than the lysogens did
(Table 2), although the difference was not statistically significant.
Considering possible variation in response to CT among individual
rabbits, the number of observations was possibly less than optimum for
observation of a statistically significant difference between the two
groups. Nevertheless, these results confirmed a previous observation
(15) that strains carrying the RF of CTX
produce
biologically active CT in their culture supernatants.
as well as
the native toxigenic strains P-27459 and MO10 produced severe diarrhea
in rabbits. On the other hand, the attRS-negative strains
carrying the RF of the CTX
genome were either negative or produced
mild diarrhea (Table 3). Differences between the proportions of rabbits responding with fatal or nonfatal diarrhea to CTX
lysogens and to
strains carrying the RF of CTX
were statistically significant (P < 0.001). Differences between the proportions of
rabbits responding with diarrhea to native non-O1 strains and their
derivatives carrying the RF of CTX
were also statistically
significant (P = 0.001).
To examine the reason for the apparent inability of most
attRS-negative strains to cause diarrhea, we monitored the
stability of the CTX
genome in these strains (Table
4). Analysis of strains excreted
by the challenged rabbits for the presence of the phage genome showed
that a high proportion of cells (75 to 90%) lost the unintegrated
phage genome in the first 24 h, whereas almost 99% of cells
became negative for pMSF8.2 by 48 h. In the lysogens, however,
100% of the excreted cells retained the CTX
genome. These
results suggested that only strains carrying the integrated CTX
genome can cause full-blown disease. It may be mentioned that toxigenic
strains isolated from cholera patients have always been found to carry
the phage genome in the prophage state. Expression of critical
virulence genes in V. cholerae is known to be coordinately regulated, so that multiple genes respond in a similar fashion to
environmental conditions (3). Coordinate expression of
virulence genes results from the activity of a cascading system of
regulatory factors. The pathogenesis of cholera involves a sequential
expression of two major virulence factors (16). These
include the colonization factor TCP and the enterotoxin CT, both of
which are under the regulation of ToxR, a 32-kDa transmembrane protein.
In the present study the time to development of diarrhea and the
duration of diarrhea in rabbits challenged with CTX
lysogens were
longer than those for strains carrying the RF (Table 3). The challenge strains were excreted by all rabbits for at least 6 days, suggesting colonization of the intestines by the strains and hence adequate expression of colonization factors. The mild and short-lived diarrhea observed in some rabbits challenged with strains carrying the RF thus
appears to be a response to toxins produced early in the experiment
from the RF of CTX
, which is known to occur independently of ToxR.
After this, the CTX
genome was probably lost, rendering the cells
nontoxigenic. The results of this study thus suggest that for a
diarrheal response like that seen in cholera, a sustained expression of
the ctxAB genes is required.
|
Diarrheal response to non-O1 non-O139 strains.
In the present
study, although the native non-O1-non-O139 strains did not cause
diarrhea in the rabbit model (Table 3), 14 of 22 rabbits (63.6%)
inoculated with V. cholerae non-O1 non-O139 strains carrying
pMSF8.2 developed mild to moderate diarrhea. While the O1 and O139
strains carried genes for the colonization factor TCP, the non-O1
non-O139 strains were TCP negative. Apparent colonization of rabbit
intestines by these TCP-negative strains suggests that these strains
probably produce some other, unknown colonization factors. Further
studies are under way in our laboratory to characterize possible new
colonization factors produced by the TCP-negative clinical strains. The
diarrhea caused by non-O1 non-O139 strains carrying the RF of the
CTX
derivative was of short duration (12 to 36 h), and the
strains when excreted were mostly CT negative due to in vivo loss of
the RF DNA. This scenario resembles clinical cases of diarrhea due to
non-O1 vibrios, when strains cultured from the stool are usually CT
negative (23). Besides the possibility of the diarrhea
being induced by additional, unknown virulence factors, it also seems
possible that in the natural habitat some non-O1 strains become
transiently toxigenic by acquisition of CTX
. Such strains are not
normally detected until they infect a host and produce diarrhea. The
CTX
genome is probably lost in the intestinal tract following
infection and production of mild diarrhea by such strains. However, it
is not clear what determines the stability of the unintegrated CTX
genome in these cells under environmental conditions prior to infecting a mammalian host. An alternative explanation may be that such strains
acquire the phage genome while inside the intestine of the host and
transiently produce CT.
Selection of CTX
lysogens in the intestine.
Previous
studies have suggested that in the gastrointestinal environment
expression of CT confers a survival advantage to V. cholerae
and that hypertoxigenic strains are selected in vivo by a need to
upregulate the expression of CT. In the present study, strains carrying
the RF of CTX
rapidly lost the phage genome in vivo, whereas strains
carrying the integrated form of the phage retained the phage genome. We
also examined the stability of the RF in V. cholerae cells
under in vitro conditions. Although normally the
Kmr-labeled phage genome was retained by the
recipient cells when grown in the presence of kanamycin, a proportion
of the cells lost the phage genome in the absence of kanamycin.
However, the loss of the phage genome in vitro was more gradual than
that in vivo. After 24 h of culture in the absence of kanamycin,
15 to 32% of cells lost the phage genome in vitro, whereas the
frequency of loss in the rabbit intestine was between 75 and 90% for
all strains tested after the first 24 h. This was unexpected,
particularly since in the intestine, where TCP is adequately expressed,
the CTX
is expected to be maintained in the cells due to continuous reinfection (15). Thus, the gastrointestinal tract seems
to select CTX
lysogens rather than strains carrying the RF, although the latter strains produced higher levels of CT when assayed in vitro.
This may explain why all naturally occurring toxigenic strains of
V. cholerae carry the CTX
genome in the lysogenic form
and particularly in serogroups which are capable of causing human
disease. CTX
is different from the well-characterized filamentous bacteriophages derived from E. coli in that this phage has
evolved to possess genes for a site-specific integration system.
Integration of the CTX
genome into the host chromosome seems to
allow it to withstand the intestinal selection, whereas the ability of the prophage to enter the replicative state maximizes horizontal propagation.
Implications for vaccine development.
The development of live
oral vaccines against cholera invariably involves the deletion of the
ctxA gene encoding the enzymatic subunit of CT or of the
entire CTX element, thus rendering the strain nontoxigenic. The
discovery of CTX
has shown that the possibility of reversion of
attenuated strains by reacquisition of the CTX
genome is real. The
receptor for CTX
for entry into a recipient V. cholerae
cell is the TCP, which is also the major colonization factor. Since to
elicit an adequate immune response live vaccines must colonize the
intestine, TCP is retained in vaccine strains. A recent approach to
protect attenuated live vaccine strains from lysogenic conversion by
CTX
involves deleting the attRS sequence, thus impairing
the chromosomal integration of the CTX
genome. Thus, although the
attenuated strains remain susceptible to infection by CTX
, in
strains with the attRS sequence deleted the phage genome is
expected to exist as a replicative plasmid. In the present study, we
found that such strains with the RF of CTX
lose the phage genome
when introduced into the intestines of rabbits. The diarrheal response,
if any, was mild, and the excreted strains were mostly nontoxigenic.
These results confirmed that attenuated vaccine strains with
attRS deletions are considerably protected from generating
stable toxigenic revertants.
| |
ACKNOWLEDGMENTS |
|---|
This research was funded in part by the U.S. Agency for International Development under grant HRN-5986-A-00-6005-00 with the ICDDR,B and by the National Institutes of Health under grant RO1 AI39129-01A1 with the Department of International Health, Johns Hopkins University, and ICDDR,B. The ICDDR,B is supported by countries and agencies which share its concern for the health problems of developing countries.
We thank Tasnim Azim for help with the data analysis and Afjal Hossain for secretarial assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Genetics Laboratory, Laboratory Sciences Division, ICDDR,B. GPO Box 128, Dhaka-1000, Bangladesh. Phone: 880 2 8811751 to 880 2 8811760. Fax: 880 2 8812529 and 880 2 8823116. E-mail: faruque{at}icddrb.org.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattie, D. R. Spriggs, J. R. Kenner, A. Trofa, J. C. Sadoff, J. J. Mekalanos, and D. N. Taylor. 1995. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 354:949-952. |
| 2. | De, S. N., and D. N. Chatterje. 1953. An experimental study of the mechanisms of action of Vibrio cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 46:559-562[CrossRef]. |
| 3. | DiRita, V. J. 1992. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6:451-458[Medline]. |
| 4. |
Faruque, S. M.,
M. J. Albert, and J. J. Mekalanos.
1998.
Epidemiology, genetics and ecology of toxigenic Vibrio cholerae.
Microbiol. Mol. Biol. Rev.
62:1301-1314 |
| 5. |
Faruque, S. M.,
Asadulghani,
A. R. M. A. Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic V. cholerae O1 and O139.
Infect. Immun.
66:3752-3757 |
| 6. |
Faruque, S. M.,
Asadulghani,
M. N. Saha,
A. R. M. A. Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTX : molecular basis for the origination of new strains with epidemic potential.
Infect. Immun.
66:5819-5825 |
| 7. |
Faruque, S. M.,
M. M. Rahman,
Asadulghani,
K. M. N. Islam, and J. J. Mekalanos.
1999.
Lysogenic conversion of environmental Vibrio mimicus strains by CTX .
Infect. Immun.
67:5723-5729 |
| 8. | Faruque, S. M., K. M. Ahmed, A. R. M. A. Alim, F. Qadri, A. K. Siddique, and M. J. Albert. 1997. Emergence of a new clone of toxigenic Vibrio cholerae biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh. J. Clin. Microbiol. 35:624-630[Abstract]. |
| 9. | Feinberg, A., and B. Volgelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267[CrossRef][Medline]. |
| 10. |
Goldberg, I., and J. J. Mekalanos.
1986.
Effect of a recA mutation on cholera toxin gene amplification and deletion events.
J. Bacteriol.
165:723-731 |
| 11. |
Janda, J. M.,
C. Powers,
R. G. Bryant, and S. L. Abbott.
1988.
Current perspective on the epidemiology and pathogenesis of clinically significant Vibrio spp.
Clin. Microbiol. Rev.
1:245-267 |
| 12. | Kaper, J. B., J. G. Morris Jr, and M. Nishibuchi. 1988. DNA probes for pathogenic Vibrio species, p. 65-77. In F. C. Tenover (ed.), DNA probes for infectious disease. CRC Press, Inc., Boca Raton, Fla. |
| 13. | Keasler, S. P., and R. H. Hall. 1993. Detection and biotyping of Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 341:1661[CrossRef][Medline]. |
| 14. | Kenner, J. R., T. S. Coster, D. N. Taylor, A. F. Trofa, M. Barrera-Oro, T. Hyman, J. M. Adams, D. T. Beattie, K. P. Killeen, D. R. Spriggs, J. J. Mekalanos, and J. C. Sadoff. 1995. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J. Infect. Dis. 172:1126-1129[Medline]. |
| 15. |
Lazar, S., and M. K. Waldor.
1998.
ToxR-independent expression of cholera toxin from the replicative form of CTX .
Infect. Immun.
66:394-397 |
| 16. | Lee, S. H., D. L Hava, M. K. Waldor, and A. Camilli. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625-634[CrossRef][Medline]. |
| 17. |
Lin, Wei,
K. J. Fullner,
R. Clayton,
J. A. Sexton,
M. B. Rogers,
K. E. Calia,
S. B. Calderwood,
C. Fraser, and J. J. Mekalanos.
1999.
Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage.
Proc. Natl. Acad. Sci. USA
96:1071-1076 |
| 18. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 19. |
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475 |
| 20. |
Pearson, G. D. N.,
A. Woods,
A., S. L. Chiang, and J. J. Mekalanos.
1993.
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.
Proc. Natl. Acad. Sci. USA
90:3750-3754 |
| 21. | Rabbani, G. H., and W. B. Greenough. 1990. Cholera, p. 233-253. In E. Lebenthal, and M. Duffy (ed.), Text book of secretory diarrhea. Raven Press, New York, N.Y. |
| 22. |
Sack, D. A.,
S. Huda,
P. K. B. Neogi,
R. R. Daniel, and W. M. Spira.
1980.
Microtiter ganglioside enzyme-linked immunosorbent assay for Vibrio and Escherichia coli heat labile enterotoxins and antitoxins.
J. Clin. Microbiol.
11:35-40 |
| 23. |
Sharma, C.,
M. Thungapathra,
A. Ghosh,
A. K. Mukhopadhyay,
A. Basu,
R. Mitra,
I. Basu,
S. K. Bhattacharya,
T. Shimada,
T. Ramamurthy,
T. Takeda,
S. Yamasaki,
Y. Takeda, and G. B. Nair.
1998.
Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.
J. Clin. Microbiol.
36:756-763 |
| 24. |
Spira, W. M.,
R. B. Sack, and J. L. Froehlich.
1981.
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea.
Infect. Immun.
32:739-747 |
| 25. | Taylor, D. N., K. P. Killeen, D. C. Hack, J. R. Kenner, T. S. Coster, D. T. Beattie, J. Ezzell, T. Hyman, A. Trofa, and M. H. Sjogren. 1994. Development of a live, oral, attenuated vaccine against El Tor cholera. J. Infect. Dis. 170:1518-1523[Medline]. |
| 26. |
Taylor, R. K.,
C. Manoil, and J. J. Mekalanos.
1989.
Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae.
J. Bacteriol.
171:1870-1878 |
| 27. | Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914[Abstract]. |
| 28. | Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 170:278-283[Medline]. |
| 29. | World Health Organization. 1974. Guidelines for the laboratory diagnosis of cholera. Bacterial Disease Unit, World Health Organization, Geneva, Switzerland. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|